117 related articles for article (PubMed ID: 22153533)
21. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
22. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
[TBL] [Abstract][Full Text] [Related]
23. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
Vaughan TL; Davis S; Kristal A; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):85-92. PubMed ID: 7742727
[TBL] [Abstract][Full Text] [Related]
24. Tooth loss is associated with increased risk of gastric non-cardia adenocarcinoma in a cohort of Finnish smokers.
Abnet CC; Kamangar F; Dawsey SM; Stolzenberg-Solomon RZ; Albanes D; Pietinen P; Virtamo J; Taylor PR
Scand J Gastroenterol; 2005 Jun; 40(6):681-7. PubMed ID: 16036528
[TBL] [Abstract][Full Text] [Related]
25. [Detection of human papillomavirus type 16 E6 mRNA in carcinomas of upper digestive tract].
Xu WG; Zhang LJ; Lu ZM; Li JY; Ke Y; Xu GW
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(21):1910-4. PubMed ID: 14642078
[TBL] [Abstract][Full Text] [Related]
26. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.
Coban S; Yüksel O; Koçkar MC; Köklü S; Basar O; Tutkak H; Ormeci N
Hepatogastroenterology; 2007; 54(77):1472-6. PubMed ID: 17708279
[TBL] [Abstract][Full Text] [Related]
27. [Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal and gastric cancer].
Tomita H; Ichikawa D; Sai S; Morimura R; Murayama Y; Komatsu S; Ikoma D; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Kokuba Y; Sakakura C; Sonoyama T; Hagiwara A; Otsuji E
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1908-10. PubMed ID: 18219849
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.
Moskal TL; Huang S; Ellis LM; Fritsche HA; Chakrabarty S
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):127-31. PubMed ID: 7742720
[TBL] [Abstract][Full Text] [Related]
29. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
[TBL] [Abstract][Full Text] [Related]
30. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer.
Loei H; Tan HT; Lim TK; Lim KH; So JB; Yeoh KG; Chung MC
J Proteome Res; 2012 Mar; 11(3):1759-72. PubMed ID: 22204653
[TBL] [Abstract][Full Text] [Related]
31. Low vitamin B
Miranti EH; Stolzenberg-Solomon R; Weinstein SJ; Selhub J; Männistö S; Taylor PR; Freedman ND; Albanes D; Abnet CC; Murphy G
Int J Cancer; 2017 Sep; 141(6):1120-1129. PubMed ID: 28568053
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of serum selenium levels and incident esophageal and gastric cancers.
Mark SD; Qiao YL; Dawsey SM; Wu YP; Katki H; Gunter EW; Fraumeni JF; Blot WJ; Dong ZW; Taylor PR
J Natl Cancer Inst; 2000 Nov; 92(21):1753-63. PubMed ID: 11058618
[TBL] [Abstract][Full Text] [Related]
33. Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma.
Zhang B; Zhang Z; Zhang X; Gao X; Kernstine KH; Zhong L
Biomarkers; 2012 Jun; 17(4):372-8. PubMed ID: 22515502
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 6 and C-reactive protein in esophageal cancer.
Groblewska M; Mroczko B; Sosnowska D; Szmitkowski M
Clin Chim Acta; 2012 Oct; 413(19-20):1583-90. PubMed ID: 22609487
[TBL] [Abstract][Full Text] [Related]
35. The potential utility of serum CA 72-4 as a marker for stage IV esophageal adenocarcinoma.
Njei B; Birk J; Vaziri H
Conn Med; 2013 Mar; 77(3):141-5. PubMed ID: 23593659
[TBL] [Abstract][Full Text] [Related]
36. Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank.
McMenamin ÚC; Liu P; Kunzmann AT; Cook MB; Coleman HG; Johnston BT; Cantwell MM; Cardwell CR
Am J Gastroenterol; 2021 Mar; 116(3):522-529. PubMed ID: 33156012
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers.
Chen W; Dawsey SM; Qiao YL; Mark SD; Dong ZW; Taylor PR; Zhao P; Abnet CC
Br J Cancer; 2007 Jul; 97(1):123-8. PubMed ID: 17551495
[TBL] [Abstract][Full Text] [Related]
38. Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment.
Kefeli U; Yildirim ME; Aydin D; Madenci OC; Yasar N; Sener N; Mert AG; Yuksel S; Ercelep OB; Korkmaz T; Yildiz R; Gumus M
Biomarkers; 2012 Nov; 17(7):663-7. PubMed ID: 22889408
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of serum cysteine levels and oesophageal and gastric cancers in China.
Murphy G; Fan JH; Mark SD; Dawsey SM; Selhub J; Wang J; Taylor PR; Qiao YL; Abnet CC
Gut; 2011 May; 60(5):618-23. PubMed ID: 21242262
[TBL] [Abstract][Full Text] [Related]
40. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
